Aker BioMarine AS reported earnings results for the second quarter and six months ended June 30, 2022. For the second quarter, the company reported sales was USD 73.4 million compared to USD 74.3 million a year ago. Net income was USD 15 million compared to net loss of USD 3.2 million a year ago. Basic earnings per share from continuing operations was USD 0.17 compared to basic loss per share from continuing operations of USD 0.04 a year ago. Diluted earnings per share from continuing operations was USD 0.17 compared to diluted loss per share from continuing operations of USD 0.04 a year ago.
For the six months, sales was USD 130.3 million compared to USD 124.4 million a year ago. Net income was USD 5.3 million compared to net loss of USD 13.1 million a year ago. Basic earnings per share from continuing operations was USD 0.06 compared to basic loss per share from continuing operations of USD 0.13 a year ago. Diluted earnings per share from continuing operations was USD 0.06 compared to diluted loss per share from continuing operations of USD 0.13 a year ago.